Literature DB >> 1743828

High energy shock waves in the treatment of delayed and nonunion of fractures.

V D Valchanou1, P Michailov.   

Abstract

The treatment of delayed and nonunion of fractures by a single extracorporeal dose of high energy shock waves generated in a water medium and focused on the fracture site is reported. The shock waves break up sclerotic bone by producing microfissures and numerous bony fragments because of the difference in impedance between bone (and calculi) and soft tissues. Osteogenesis is stimulated and contributed to union in 70 out of 82 fractures within a reasonable time. Treatment was given as an outpatient with regional anaesthesia; there were no side effects or complications.

Entities:  

Mesh:

Year:  1991        PMID: 1743828     DOI: 10.1007/bf00192289

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  3 in total

1.  Work-in-progress #1. The lithotriptor and its potential use in the revision of total hip arthroplasty.

Authors:  R R Karpman; F P Magee; T W Gruen; T Mobley
Journal:  Orthop Rev       Date:  1987-01

2.  Side effects of extracorporeal shock-wave exposure in patients treated by extracorporeal shock-wave lithotripsy for upper urinary tract stone.

Authors:  T Kishimoto; K Yamamoto; T Sugimoto; H Yoshihara; M Maekawa
Journal:  Eur Urol       Date:  1986       Impact factor: 20.096

3.  Extracorporeally induced destruction of kidney stones by shock waves.

Authors:  C Chaussy; W Brendel; E Schmiedt
Journal:  Lancet       Date:  1980-12-13       Impact factor: 79.321

  3 in total
  46 in total

Review 1.  In-vehicle extremity injuries from improvised explosive devices: current and future foci.

Authors:  Arul Ramasamy; Spyros D Masouros; Nicolas Newell; Adam M Hill; William G Proud; Katherine A Brown; Anthony M J Bull; Jon C Clasper
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-01-27       Impact factor: 6.237

2.  The effect of extracorporeal shock wave therapy on lower limb spasticity in subacute stroke patients.

Authors:  Seung Won Moon; Jin Hoan Kim; Mi Jin Jung; Seungnam Son; Joong Hoon Lee; Heesuk Shin; Eun Shin Lee; Chul Ho Yoon; Min-Kyun Oh
Journal:  Ann Rehabil Med       Date:  2013-08-26

3.  Acoustic field characterization of the Duolith: measurements and modeling of a clinical shock wave therapy device.

Authors:  Camilo Perez; Hong Chen; Thomas J Matula; Maria Karzova; Vera A Khokhlova
Journal:  J Acoust Soc Am       Date:  2013-08       Impact factor: 1.840

4.  [Extracorporal shock wave therapy for the treatment of pseudarthrosis : New experiences with an old technology].

Authors:  J Everding; M Freistühler; J Stolberg-Stolberg; M J Raschke; P Garcia
Journal:  Unfallchirurg       Date:  2017-11       Impact factor: 1.000

5.  Case study: shock waves treatment of diabetic gangrene.

Authors:  Danilo Jankovic
Journal:  Int Wound J       Date:  2011-03-08       Impact factor: 3.315

6.  Best one hundred papers of International Orthopaedics: a bibliometric analysis.

Authors:  Andreas F Mavrogenis; Panayiotis D Megaloikonomos; Georgios N Panagopoulos; Cyril Mauffrey; Andrew Quaile; Marius M Scarlat
Journal:  Int Orthop       Date:  2017-01-04       Impact factor: 3.075

7.  [Extracorporeal shock wave therapy as a treatment of a non-healing chronic leg ulcer].

Authors:  M Stieger; J-P Schmid; S Bajrami; T Hunziker
Journal:  Hautarzt       Date:  2013-06       Impact factor: 0.751

8.  Arthroscopy surgery versus shock wave therapy for chronic calcifying tendinitis of the shoulder.

Authors:  Enrico Rebuzzi; Nicolò Coletti; Stefano Schiavetti; Fernando Giusto
Journal:  J Orthop Traumatol       Date:  2008-08-08

9.  Extracorporeal shockwave therapy: A systematic review of its use in fracture management.

Authors:  Ba Petrisor; Selene Lisson; Sheila Sprague
Journal:  Indian J Orthop       Date:  2009-04       Impact factor: 1.251

10.  The science of electrical stimulation therapy for fracture healing.

Authors:  Paul Rt Kuzyk; Emil H Schemitsch
Journal:  Indian J Orthop       Date:  2009-04       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.